Ausgabe 12/2014
Inhalt (17 Artikel)
Vitamin D and skeletal health in infancy and childhood
R. J. Moon, N. C. Harvey, J. H. Davies, C. Cooper
Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?
R. Sapir-Koren, G. Livshits
Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures
S. D. Nelson, R. E. Nelson, G. W. Cannon, P. Lawrence, M. J. Battistone, M. Grotzke, Y. Rosenblum, J. LaFleur
Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy
B. Hofstetter, S. Gamsjaeger, F. Varga, H. Dobnig, J. J. Stepan, H. Petto, I. Pavo, K. Klaushofer, E. P. Paschalis
Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider
I. Kyvernitakis, K. Kostev, A. Kurth, U. S. Albert, P. Hadji
Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
M. A. Paggiosi, N. Peel, E. McCloskey, J. S. Walsh, R. Eastell
Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats
H. B. Jia, J. X. Ma, X. L. Ma, J. T. Yu, R. Feng, L. Y. Xu, J. Wang, D. Xing, S. W. Zhu, Y. Wang
Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients
K. Ebina, J. Hashimoto, K. Shi, M. Kashii, M. Hirao, H. Yoshikawa
Vitamin D insufficiency over 5 years is associated with increased fracture risk—an observational cohort study of elderly women
D. Buchebner, F. McGuigan, P. Gerdhem, J. Malm, M. Ridderstråle, K. Åkesson
Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA
A. Wilk, S. Sajjan, A. Modi, C.-P. S. Fan, P. Mavros
A trabecular plate-like phenotype is overrepresented in Chinese-American versus Caucasian women
M. D. Walker, S. Shi, J. J. Russo, X. S. Liu, B. Zhou, C. Zhang, G. Liu, D. J. McMahon, J. P. Bilezikian, X. E. Guo
Associations of polymorphisms in the SOST gene and bone mineral density in postmenopausal Chinese Women
H. Zhang, J. W. He, C. Wang, Z. Zhang, H. Yue, W. W. Hu, J. M. Gu, Y. Q. Hu, M. Li, W. Z. Fu, Z. L. Zhang
Incidence and risk factors for osteoporotic vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The São Paulo Ageing & Health (SPAH) Study
D. S. Domiciano, L. G. Machado, J. B. Lopes, C. P. Figueiredo, V. F. Caparbo, L. Takayama, R. M. Oliveira, P. R. Menezes, R. M. R. Pereira
Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?
W. D. Leslie, S. N. Morin, L. M. Lix, S. R. Majumdar
A Frailty Index predicts 10-year fracture risk in adults age 25 years and older: results from the Canadian Multicentre Osteoporosis Study (CaMos)
C. C. Kennedy, G. Ioannidis, K. Rockwood, L. Thabane, J. D. Adachi, S. Kirkland, L. E. Pickard, A. Papaioannou
Association of stressful life events with accelerated bone loss in older men: the osteoporotic fractures in men (MrOS) study
H. A. Fink, M. A. Kuskowski, J. A. Cauley, B. C. Taylor, J. T. Schousboe, P. M. Cawthon, K. E. Ensrud
Erratum to: Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005–2008: is treatment with bisphosphonates an option?
R. Lubwama, A. Nguyen, A. Modi, D. Chirovsky, P. D. Miller